Drug: RIBAVIRIN. Injury: Hepatitis C Quarter: 2016Q3
Total Records: 70 Number of Pages: 4
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125985492 | RIBAVIRIN. | Hepatitis C | MERCK | 0.00 | M | 86 KG | 20160801 | FR |
| 126032041 | RIBAVIRIN. | Hepatitis C | GILEAD | 50.00 YR | F | 0 | 20160728 | US |
| 126032701 | RIBAVIRIN. | Hepatitis C | GILEAD | 62.00 YR | F | 79 KG | 20160728 | US |
| 126092542 | RIBAVIRIN. | Hepatitis C | AUROBINDO | 56.00 YR | F | 0 | 20160921 | GB |
| 126146052 | RIBAVIRIN. | Hepatitis C | MERCK | 56.00 YR | F | 0 | 20160915 | GB |
| 126156031 | RIBAVIRIN. | Hepatitis C | MERCK | 0.00 | 0 | 20160802 | PK | |
| 126160762 | RIBAVIRIN. | Hepatitis C | MERCK | 42.00 YR | F | 0 | 20160805 | IT |
| 126160772 | RIBAVIRIN. | Hepatitis C | MERCK | 53.00 YR | M | 0 | 20160826 | GB |
| 126240772 | RIBAVIRIN. | Hepatitis C | AUROBINDO | 53.00 YR | M | 0 | 20160907 | GB |
| 126278701 | RIBAVIRIN. | Hepatitis C | ABBVIE | 60.00 YR | M | 0 | 20160806 | PR |
| 126282301 | RIBAVIRIN. | Hepatitis C | ROCHE | 62.00 YR | M | 80 KG | 20160808 | CA |
| 126349972 | RIBAVIRIN. | Hepatitis C | GILEAD | 0.00 | M | 0 | 20160817 | US |
| 126350362 | RIBAVIRIN. | Hepatitis C | GILEAD | 51.00 YR | F | 0 | 20160901 | US |
| 126392752 | RIBAVIRIN. | Hepatitis C | ROCHE | 0.00 | F | 0 | 20160922 | GB |
| 126430401 | RIBAVIRIN. | Hepatitis C | ROCHE | 58.00 YR | M | 0 | 20160811 | CA |
| 126450831 | RIBAVIRIN. | Hepatitis C | GILEAD | 57.00 YR | F | 0 | 20160811 | US |
| 126511971 | RIBAVIRIN. | Hepatitis C | MERCK | 0.00 | 0 | 20160815 | CH | |
| 126560591 | RIBAVIRIN. | Hepatitis C | ROCHE | 0.00 | F | 0 | 20160816 | US |
| 126578632 | RIBAVIRIN. | Hepatitis C | MERCK | 0.00 | F | 0 | 20160928 | GB |
| 126622252 | RIBAVIRIN. | Hepatitis C | GILEAD | 63.00 YR | M | 71 KG | 20160822 | US |
Total Records: 70 Number of Pages: 4